Select your country

Websites worldwide

Select a country to go to the website of the respective STADA sales company.

Australia (1)

Austria (1)

Belarus (1)

Belgium (1)

Bosnia-Herzegovina (1)

Bulgaria (1)

China (1)

Croatia (1)

Czech Republic (2)

Denmark (1)

France (1)

Germany (3)

Hungary (1)

Ireland (1)

Italy (1)

Montenegro (1)

Netherlands (2)

Poland (1)

Portugal (1)

Romania (1)

Saudi Arabia (1)

Serbia (1)

Slovakia (1)

Slovenia (1)

Spain (1)

Switzerland (1)

The Phillippines (1)

United Arab Emirates (1)

United Kingdom (3)

Vietnam (2)

< Back

STADA: Successful refinancing through the securing of additional promissory note loans of a total of Euro 350 million

  • 26/04/2016
  • Press Release

Bad Vilbel, April 26, 2016 –

STADA Arzneimittel AG has secured additional promissory note loans of a total of Euro 350 million. With the new promissory note loans, STADA has refinanced promissory note loans in the amount of Euro 188.0 million, which will expire in December 2016.


The promissory note loans, which are divided into four tranches and have terms of between five and seven years, have both fixed and variable interest rates. The securing of the refinancing sum will result in significant annual interest savings in future.


“As a result of the high demand from numerous promissory note investors, we were able to place a much higher volume than originally planned. The successful transaction highlights STADA’s access to the debt market and allows us to further expand our maturity profile at attractive conditions. Overall, we are therefore well-equipped for future growth”, says Helmut Kraft, Chief Financial Officer of STADA Arzneimittel AG, of the successful refinancing.
The transaction was supported by Landesbank Hessen-Thüringen and Landesbank Baden-Württemberg.


Additional information for analysts:
STADA Arzneimittel AG / Investor Relations / Stadastraße 2–18 / 61118 Bad Vilbel – Germany /
Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-215 / E-mail: [email protected]

Additional information for journalists:
STADA Arzneimittel AG / Media Relations / Stadastraße 2–18 / 61118 Bad Vilbel – Germany /
Phone: +49 (0) 6101 603-165 / Fax: +49 (0) 6101 603-215 / E-mail: [email protected]